Alimera Sciences Inc - Company Profile
Powered by 
All the sales intelligence you need on Alimera Sciences Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Alimera Sciences Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Alimera Sciences Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Alimera Sciences Inc (Alimera), a subsidiary of ANI Pharmaceuticals Inc, is a research based pharmaceutical company that markets prescription ophthalmic pharmaceuticals. The company's commercialized products: Iluvien and Yutiq, strong position in the rare disease market, and focus on research and development activities are its strength areas, even as dependence on distributors could be a serious cause for concern. The company could benefit from the acquisition by ANI Pharmaceuticals, positive outlook for type 2 diabetes market, and Iluvien for other eye diseases. However, high competition, government regulations, and dependence on third-party manufacturers could limit Alimera's growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer